{"organizations": [], "uuid": "cb55e8a792030a15dddce95d74017e423c0b08e0", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/2", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/05/22/pr-newswire-nobilis-health-corp-names-phil-ayres-chief-marketing-officer.html", "country": "US", "domain_rank": 767, "title": "Nobilis Health Corp. Names Phil Ayres Chief Marketing Officer", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-23T01:11:00.000+03:00", "replies_count": 0, "uuid": "cb55e8a792030a15dddce95d74017e423c0b08e0"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/05/22/pr-newswire-nobilis-health-corp-names-phil-ayres-chief-marketing-officer.html", "ord_in_thread": 0, "title": "Nobilis Health Corp. Names Phil Ayres Chief Marketing Officer", "locations": [], "entities": {"persons": [{"name": "phil ayres", "sentiment": "negative"}, {"name": "nobil", "sentiment": "negative"}, {"name": "ayres", "sentiment": "none"}, {"name": "nobilis", "sentiment": "none"}, {"name": "kenneth efird", "sentiment": "none"}, {"name": "phil", "sentiment": "none"}], "locations": [{"name": "houston", "sentiment": "none"}, {"name": "nobilis", "sentiment": "none"}], "organizations": [{"name": "nobilis health corp.", "sentiment": "negative"}, {"name": "nobilis health corp", "sentiment": "negative"}, {"name": "nyse", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "HOUSTON, May 22, 2018 /PRNewswire/ -- Nobilis Health Corp. (NYSE American: HLTH) (NEO: HLTH) (\"Nobilis\" or the \"Company\") announced today that it has promoted Phil Ayres, Nobilis' Vice President of Marketing, to Chief Marketing Officer, effective today.\n\"Phil has done a wonderful job optimizing our marketing efforts since he joined our team last June,\" said Kenneth Efird, President. \"In the first quarter, Phil's team oversaw a year-over-year 28% reduction in total marketing expenses, driven by lower customer acquisition costs and increased patient conversion in 2018. Phil has executed on all of the initiatives he has overseen during his tenure as Vice President of Marketing at Nobilis. As Chief Marketing Officer, Phil will continue building out our marketing team and the platform's capabilities, making Nobilis more effective and increasing our impact in new and existing markets.\"\n\"I am excited to take on this role as we continue to expand our highly scalable approach to direct to consumer healthcare marketing,\" Ayres said. \"Our investment in building an unparalleled direct to consumer healthcare web platform reflects the substantial role of digital marketing in Nobilis' growth. My background with digital marketing giants Travelocity and Hotels.com taught me how to execute digital marketing strategies at scale, and I look forward to continuing to bring those strategies to Nobilis Health in the Chief Marketing Officer role.\"\nAbout Nobilis Health Corp.\nNobilis Health ( www.NobilisHealth.com ) is a full-service healthcare development and management company, with more than 30 locations across Texas and Arizona, including hospitals, ambulatory surgery centers, and multi-specialty clinics. In addition, Nobilis Health partners with more than 30 facilities across the country. Marketing nine independent brands, Nobilis Health deploys a unique patient acquisition strategy driven by proprietary, direct-to-consumer marketing technology, focusing on a specified set of procedures that are performed at its facilities by local physicians. Nobilis Health's business model connects patients with physicians and delivers the highest quality healthcare.\nForward-Looking Statements\nThis press release contains certain within the meaning of Canadian and United States securities laws, including the safe harbor for contained in the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts and may be identified by the use of words such as \"may,\" \"believe,\" \"will,\" \"expect,\" \"project,\" \"estimate,\" \"anticipate,\" \"plan\" or \"continue.\" These are based on current plans and expectations and are subject to a number of risks, uncertainties and other factors which could significantly affect current plans and expectations and our future financial condition and results. These factors, which could cause actual results, performance and achievements to differ materially from those anticipated, include, but are not limited to our ability to successfully maintain effective internal controls over financial reporting; our ability to implement our business strategy, manage the growth in our business, and integrate acquired businesses; the risk of litigation and investigations, and liability claims for damages and other expenses not covered by insurance; the risk that payments from third-party payers, including government healthcare programs, may decrease or not increase as costs increase; adverse developments affecting the medical practices of our physician limited partners; our ability to maintain favorable relations with our physician limited partners; our ability to grow revenues by increasing case and procedure volume while maintaining profitability at the Nobilis facilities; failure to timely or accurately bill for services; our ability to compete for physician partners, patients and strategic relationships; the risk of changes in patient volume and patient mix; the risk that laws and regulations that regulate payments for medical services made by government healthcare programs could cause our revenues to decrease; the risk that contracts are cancelled or not renewed or that we are not able to enter into additional contracts under terms that are acceptable to us; and the risk of potential decreases in our reimbursement rates. The foregoing are significant factors we think could cause our actual results to differ materially from expected results. However, there could be additional factors besides those listed herein that also could affect us in an adverse manner.\nWe have not undertaken any obligation to publicly update or revise any . All of our speak only as of the date of the document in which they are made or, if a date is specified, as of such date. Subject to a mandatory requirements of applicable law, we disclaim any obligation or undertaking to provide any updates or revisions to any forward-looking statement to reflect any change in our expectations or any changes in events, conditions, circumstances or information on which the forward-looking statement is based. All subsequent written and oral attributable to us or persons acting on our behalf are expressly qualified in their entirety by the foregoing factors and in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017, filed on March 12, 2018, as updated by other filings Commission.\nContact Information:\nJoel Lehr\nAVP of Corporate Communications\n(346) 207-6342\nIR@Nobilishealth.com\nView original content with multimedia: http://www.prnewswire.com/news-releases/nobilis-health-corp-names-phil-ayres-chief-marketing-officer-300653134.html\nSOURCE Nobilis Health Corp.", "external_links": ["http://www.prnewswire.com/news-releases/nobilis-health-corp-names-phil-ayres-chief-marketing-officer-300653134.html", "http://www.nobilishealth.com/"], "published": "2018-05-23T01:11:00.000+03:00", "crawled": "2018-05-23T03:41:14.000+03:00", "highlightTitle": ""}